pulsation of the PARI SINUS2, it allows efficient deposition in the sinuses. Supplied with: • PARI LC SPRINT SINUS nebuliser • PARI LC SPRINT SINUS Year Pack • PARI LC SPRINT...

captured. The retention rate of the PARI pads is equivalent to that of a FFP2 mask*. The efficiency of the PARI Filter Valve Set in combination with a PARI LC SPRINT or PARI LC...

respiratory therapies. Dr Schwenck’s recent position at PARI was Portfolio Manager of eFlow Partnering until he left the company in June 2022. About PARI PARI Pharma develops and...

June 25, 2021 Dr. Stefan Seemann is appointed President of PARI Pharma GmbH Dr. Stefan Seemann will replace Dr. Martin Knoch as President of PARI Pharma GmbH on July 1, 2021. Read...

NEWS Monday, 01. April 2019 The In Vitro effect of nebulized hypertonic saline on human bronchial epithelium (HBE) Nebulized hypertonic saline (HS) is an effective approach in...

Pierre-Régis Burgel is a renowned expert in respiratory medicine at the Institut Cochin, Université Paris Cité. He is involved in many clinical and basic research studies in...

® device to Dr. Stefan Seemann. © PARI Pharma GmbH. About PARI and PARI Pharma As a manufacturer of medical devices and medicinal products for inhalation therapy, PARI is the...

trademark of PARI Pharma GmbH. eFlow ® is a registered trademark of PARI Pharma GmbH. Contact: Michael Hahn Director eFlow Partnering PARI Pharma GmbH +49 (0) 89 74 28 46 -831...

trademark of PARI Pharma GmbH. eFlow ® is a registered trademark of PARI Pharma GmbH. Contact: Michael Hahn Director eFlow Partnering & Strategy PARI Pharma GmbH +49 (0) 89 74 28...

eFlow Development and Operations at PARI Pharma. About PARI Pharma GmbH and eFlow Technology PARI is a world leader in the development of aerosol delivery devices. PARI Pharma...